Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunter Wolf

Showing results (31-40 of 314) with videos related to

Pageof 32
Sort By:
American Journal of Nephrology|August 28, 2020
AGE-Induced Suppression of EZH2 Mediates Injury of Podocytes by Reducing H3K27me3Marita Liebisch, Gunter Wolf
American Journal of Physiology. Renal Physiology|January 1, 2015
Morg1 heterozygous deficiency ameliorates hypoxia-induced acute renal injuryIvonne Loeffler, Gunter Wolf
Genes|March 25, 2022
Cloning of the Human <i>MORG1</i> Promoter: Differential Regulation by Hypoxia and Prolyl-Hydroxylase InhibitorsTzvetanka Bondeva, Gunter Wolf
Journal of the American Society of Nephrology : JASN|August 10, 2007
Angiotensin II-induced reactive oxygen species and the kidneyAnja Sachse, Gunter Wolf
Journal of the American Society of Nephrology : JASN|July 2, 2011
Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesisChristiane Rüster, Gunter Wolf
Journal of Clinical Medicine|August 5, 2015
Role of Neuropilin-1 in Diabetic NephropathyTzvetanka Bondeva, Gunter Wolf
Seminars in Nephrology|February 5, 2013
The role of the renin-angiotensin-aldosterone system in obesity-related renal diseasesChristiane Rüster, Gunter Wolf
Journal of the American Society of Nephrology : JASN|April 23, 2003
Diabetic nephropathy in type 2 diabetes prevention and patient managementGunter Wolf, Eberhard Ritz
Journal of the American Society of Nephrology : JASN|October 13, 2006
Renin-angiotensin-aldosterone system and progression of renal diseaseChristiane Rüster, Gunter Wolf
Kidney International|February 9, 2005
Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indicationsGunter Wolf, Eberhard Ritz
Pageof 32

Showing results (31-40 of 314) with videos related to

Sort By:
Pageof 32
American Journal of Nephrology|August 28, 2020
AGE-Induced Suppression of EZH2 Mediates Injury of Podocytes by Reducing H3K27me3Marita Liebisch, Gunter Wolf
American Journal of Physiology. Renal Physiology|January 1, 2015
Morg1 heterozygous deficiency ameliorates hypoxia-induced acute renal injuryIvonne Loeffler, Gunter Wolf
Genes|March 25, 2022
Cloning of the Human <i>MORG1</i> Promoter: Differential Regulation by Hypoxia and Prolyl-Hydroxylase InhibitorsTzvetanka Bondeva, Gunter Wolf
Journal of the American Society of Nephrology : JASN|August 10, 2007
Angiotensin II-induced reactive oxygen species and the kidneyAnja Sachse, Gunter Wolf
Journal of the American Society of Nephrology : JASN|July 2, 2011
Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesisChristiane Rüster, Gunter Wolf
Journal of Clinical Medicine|August 5, 2015
Role of Neuropilin-1 in Diabetic NephropathyTzvetanka Bondeva, Gunter Wolf
Seminars in Nephrology|February 5, 2013
The role of the renin-angiotensin-aldosterone system in obesity-related renal diseasesChristiane Rüster, Gunter Wolf
Journal of the American Society of Nephrology : JASN|April 23, 2003
Diabetic nephropathy in type 2 diabetes prevention and patient managementGunter Wolf, Eberhard Ritz
Journal of the American Society of Nephrology : JASN|October 13, 2006
Renin-angiotensin-aldosterone system and progression of renal diseaseChristiane Rüster, Gunter Wolf
Kidney International|February 9, 2005
Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indicationsGunter Wolf, Eberhard Ritz
Pageof 32